Article
Resistance of human immunodeficiency virus type 1 to protease inhibitors: selection of resistance mutations in the presence and absence of the drug.
The Journal of general virology - 1 Mar 1996
Borman A M, Paulous S, Clavel F
Abstract excerpt
Inhibitors of the human immunodeficiency virus (HIV) protease are a promising class of antiviral agents that dramatically reduce HIV replication both in culture and in infected patients. However, as for many other antiviral compounds, long-term efficacy of these agents is impeded by the emergence of virus variants with increased resistance to their inhibitory action, following selection of specific mutations in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
